Evidence-based guidelines for cardiovascular disease prevention in women : 2007 update
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

For very narrow results

When looking for a specific result

Best used for discovery & interchangable words

Recommended to be used in conjunction with other fields

Dates
...

to

...
Document Data
Library
People
Clear All
...
Clear All

For additional assistance using the Custom Query please check out our Help Page

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners. As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i

Superseded


This Document Has Been Replaced By: Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women — 2011 Update: A Guideline from the American Heart Association

Evidence-based guidelines for cardiovascular disease prevention in women : 2007 update



Select to view the document on External site.
This document file type cannot be previewed
English
Details You May Also Like

Details:

  • Alternative Title:
    Circulation
  • Corporate Authors:
    Columbia University, USA.
  • Description:
    Worldwide, cardiovascular disease (CVD) is the largest single cause of death among women, accounting for one third of all deaths.1 In many countries, including the United States, more women than men die every year of CVD, a fact largely unknown by physicians. The public health impact of CVD in women is not related solely to the mortality rate, given that advances in science and medicine allow many women to survive heart disease. For example, in the United States, 38.2 million women (34%) are living with CVD, and the population at risk is even larger. In China, a country with a population of approximately 1.3 billion, the age-standardized prevalence rates of dyslipidemia and hypertension in women 35 to 74 years of age are 53% and 25%, respectively, which underscores the enormity of CVD as a global health issue and the need for prevention of risk factors in the first place. As life expectancy continues to increase and economies become more industrialized, the burden of CVD on women and the global economy will continue to increase.
  • Subjects:
  • Source:
    Circulation. 2007; 115(11):1481-501.
  • Document Type:
    Journal Article
  • Volume:
    115
  • Issue:
    11
  • Collection(s):
  • Main Document Checksum:
  • File Type:
    Filetype[HTM]

You May Also Like

Checkout today's featured content at stacks.cdc.gov